Skip to Main Content

Paper Details

Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects.
Blood
46
2019
Author NameAffiliation
Jenna R E Bergerson
Joie Davis
Douglas B KuhnsInc., Frederick National Laboratory for Cancer Research
  • 1 - 3

Datasets

Release 1.2